Join KACTUS and Prendio on June 18, 2025 at 11:00 AM EST, as Dr. Manhee Suh, CTO of KACTUS, unveils how cutting-edge platforms like Virus-Like Particles (VLPs), nanodiscs, and a new proprietary technology are solving key challenges in antigen presentation. In this webinar, you’ll explore:

• Strategies for expressing and stabilizing multipass transmembrane proteins

• How VLPs and nanodiscs enhance antibody discovery workflows

• Advances in structural fidelity, native orientation, and presentation

Plus: Get an exclusive look at our newest platform—designed for superior purity, correct protein orientation, and compatibility with toxic or hard-to-express targets.

Reserve your spot today to discover how next-gen antigen tools are enabling breakthroughs in immunotherapy and beyond.